Molnunat 200mg Capsule

Short Description

Molnunat 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults.

Dosage Form

Capsule

Introduction

Molnunat 200mg Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use. Molnunat 200mg Capsule should be taken orally for no longer than 5 consecutive days. It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better. The medicine may cause dizziness, headache, diarrhea, and nausea in some patients. If one experiences any such side effects, discuss them with the doctor. They may help with the treatment or suggest ways to prevent them. Before taking Molnunat 200mg Capsule, let the doctor know if you have any pre-existing medical conditions. To make sure it is safe for you, inform your doctor about all the other medications you are taking. The use of Molnunat 200mg Capsule is not recommended in pregnant women. Pregnant and breastfeeding women should consult with their doctors before taking this medicine.

Take this medicine in the dose and duration as advised by your doctor. Molnunat 200mg Capsule may be taken with or without food but it is better to take it at a fixed time.

Side Effects

No common side effects listed.

Alcohol Warning

It is not known whether it is safe to consume alcohol with Molnunat 200mg Capsule. Please consult your doctor.

Breastfeeding Warning

Molnunat 200mg Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Pregnancy Warning

Molnunat 200mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Interacting Medicines

Abacavir Adefovir Didanosine Entecavir

Molnunat 200mg Capsule is an antiviral medicine. It works by inhibiting the SARS-CoV-2 virus from replicating. This stops the virus from producing new copies and hence decreases the viral load in the body.

Do not give Molnunat 200mg Capsule to children and adolescents aged less than 18 years. Do not stop taking Molnunat 200mg Capsule without talking to your doctor first as it will protect you from becoming severely ill from COVID-19. Even after the treatment, continue practicing COVID-appropriate behavior such as wearing a mask, social distancing, and frequent handwashing. For individuals with conceiving potential, it is advisable to use contraceptive methods while taking Molnupiravir and for 4 days after the last dose of the medicine.